Immunology Journals Collection
免疫学期刊合辑
探索领域内各类期刊，发现适合您的国际期刊免疫学是医学与生命科学中的一门基础性、带动性、支柱性前沿学科，其基础理论和应用技术的快速发展推动了生物学、基础医学、药学乃至整个生命科学的发展。
在 Taylor & Francis 旗下的400余本优质医学健康相关期刊中，免疫学期刊表现尤为出色。由新发感染领域顶级期刊 Emerging Microbes & Infections (EMI) 领衔，10余本期刊位列免疫学期刊排名前 25%。
我们的免疫学期刊覆盖了广泛的主题：从免疫疗法到疫苗开发、细胞和分子免疫学、微生物发病机制、免疫毒理学等，为您的研究提供充足的选择空间。
主题征稿火热进行中👇
Autoimmune Disease
自身免疫性疾病
截稿日期：2025年7月1日
专属优惠码ZFWRR可享APC八折
Stigma and discrimination in HIV prevention and care
HIV防治中的污名与歧视
截稿日期：2026年1月31日
专属优惠码WKFVI可享APC九折
影响因子: 影响因子
2024 IF: 7.5
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile: Q1
CiteScore: CiteScore
CiteScore: 13.9
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q1
Description: Emerging Microbes & Infections publishes research related to emerging infectious diseases, including epidemic surveillance, drug discovery and vaccine development.
影响因子: 影响因子
2024 IF: 6.3
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile: Q1
CiteScore: CiteScore
CiteScore: 12.9
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q1
Description: Oncoimmunology publishes international translational and clinical research into tumor immunology including anticancer therapies and immunotherapies.
影响因子: 影响因子
2024 IF: 4.4
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile: Q2
CiteScore: CiteScore
CiteScore: 8.6
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q1
Description: Publishes open access research on immunology, focusing on the biology of the immune system, immune-based therapies and the immunological basis of disease.
影响因子: 影响因子
2024 IF: 4.8
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile: Q2
CiteScore: CiteScore
CiteScore: 11.2
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q1
Description: A MEDLINE-indexed peer-reviewed journal providing expert commentary on the development, application, and clinical effectiveness of new vaccines. Topics include vaccine technology, vaccine adjuvants, prophylactic vaccines, and therapeutic vaccines. It offers accelerated publication.
影响因子: 影响因子
2024 IF: 5.4
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile: Q1
CiteScore: CiteScore
CiteScore: 10.5
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q1
Description: Virulence publishes research on microbial pathogenesis, infection mechanisms and host–pathogen interactions to address new challenges in infectious diseases.
影响因子: 影响因子
2024 IF: 2.9
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile:
CiteScore: CiteScore
CiteScore: 11.3
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q1
Description: Publishes articles on basic and clinical immunology, autoimmunity, inflammatory and allergic diseases, vaccines and other relevant aspects of immunology. As well as review articles, the journal welcomes novel original research.
影响因子: 影响因子
2024 IF: 4.1
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile: Q2
CiteScore: CiteScore
CiteScore: 6.5
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q2
Description: Publishes open access research on inflammation, including neuroimune and molecular mechanisms, and pharmacology, mediators and cellular process of inflammation.
影响因子: 影响因子
2024 IF: 3.5
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile: Q2
CiteScore: CiteScore
CiteScore: 7.9
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q1
Description: Human Vaccines & Immunotherapeutics is an international journal of vaccinology and immunotherapy that publishes all aspects of work in these fields.
影响因子: 影响因子
2024 IF: 3.7
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile: Q2
CiteScore: CiteScore
CiteScore: 7.0
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q2
Description: A MEDLINE-indexed, peer-reviewed journal providing the latest research on the performance of new therapeutic and diagnostic modalities in clinical immunology. This journal offers accelerated publication.
影响因子: 影响因子
2024 IF: 3.0
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile: Q2
CiteScore: CiteScore
CiteScore: 6.4
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q1
Description: Publishes open access research on asthma and allergic disease, focusing on diagnosis, epidemiology, prevention and treatment, as well as pulmonary physiology. This journal offers Accelerated Publication.
影响因子: 影响因子
2024 IF: 3.1
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile: Q2
CiteScore: CiteScore
CiteScore: 6.0
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q2
Description: Addresses research on cellular and molecular
immunology as relevant to innate and adaptive immune and autoimmune responses
in health and disease, including regulatory and epigenetic mechanisms
controlling such responses.
影响因子: 影响因子
2024 IF: 2.4
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile:
CiteScore: CiteScore
CiteScore: 5.5
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile:
Description: Providing the latest advances in molecular and cellular immunology, this journal focuses on all aspects of fundamental and applied immunology.
影响因子: 影响因子
2024 IF: 2.3
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile:
CiteScore: CiteScore
CiteScore: 4.9
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q2
Description: A MEDLINE-indexed, peer-reviewed journal offering the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field. This journal offers accelerated publication.
影响因子: 影响因子
2024 IF: 2.9
影响因子最佳分区: 影响因子最佳分区
IF Best Quartile: Q2
CiteScore: CiteScore
CiteScore: 5.6
CiteScore最佳分区: CiteScore最佳分区
CiteScore Best Quartile: Q2
Description: Advances in the field of clinical immunology including autoimmune and infectious diseases that require immunological approaches from various medical fields.
了解更多免疫学及其他各学科高水平国际期刊，请访问 Taylor & Francis Group 旗下学术期刊网站， 欢迎相关学科研究人员向您青睐的期刊投稿。
期刊网站：www.tandfonline.com
医学与健康领域部分期刊已开放加速出版服务！从投稿到发表最快仅需3周！
加速出版：https://taylorandfrancis.com/partnership/commercial/accelerated-publication/
Taylor & Francis 编辑润色服务
在准备向期刊提交稿件的时候，您需要协助吗？ Taylor & Francis 编辑润色服务提供包括英语语言编辑、科学润色、翻译加编辑、稿件格式调整、相似度检查以及技术审核等，让您将时间集中在研究上。
为期刊、图书作者提供的实用指南
在您准备撰写一篇国际学术论文时，一个为您提供必要指导和资源实用网站可以为您解答许多疑问！从选刊、写作、投稿、同行评审、出版等各个方面给予详细的指导，写作投稿前的必看网站！
拥抱开放科学
开放获取对于作者、读者而言极具价值，开放科学让研究在更广泛的维度得到参考和使用，提升研究可见度和影响力，造福社会。您是否考虑发表开放获取文章？点击了解开放获取出版更多信息
联系我们
Taylor & Francis Group拥有220多年的历史，是全球领先的学术出版集团，业务包括学术期刊、图书、电子书、教科书和参考书。以高质量的学术内容和服务水平，每年出版期刊2700余种，图书14万余册。旗下包括Routledge, CRC Press, Taylor & Francis等品牌，实现全学科均衡覆盖。我们整合数据、资源和技术优势，愿为中国研究人员和中国开放科学的发展提升，贡献更多的智慧和力量。
